BACKGROUND: Small body size at birth and slow growth during the first 2 years after birth, leading to low body mass index (BMI) at 2 years, are associated with coronary heart disease and stroke in adult life. We tested the hypothesis that this path of growth is associated with an atherogenic lipid profile in later life. METHODS: We measured serum lipid concentrations at age 57-70 years in 1999 members of the Helsinki Birth Cohort. They were randomly selected from an original cohort of 8760 people and had on average 11 measurements of height and weight between birth and 2 years of age. RESULTS: The 18% of subjects who used lipid-lowering medication had a lower BMI at birth and at 2 years. These subjects were excluded from the analyses of lipid profiles. A 1 kg/m(2) lower BMI at birth was associated with 0.051 mmol/l (95% CI -0.001 to 0.103; P = 0.05) higher non-HDL cholesterol and 0.018 g/l higher (0.005-0.031; P = 0.006) apolipoprotein B concentrations. A slower increase in BMI during the first 6 months after birth was associated with lower HDL and higher non-HDL cholesterol concentrations. A 1 kg/m(2) lower BMI at 2 years was associated with 0.020 mmol/l lower (0.004-0.036; P = 0.02) HDL cholesterol and 0.059 mmol/l (0.020-0.099; P = 0.003) higher non-HDL cholesterol and 0.018 mmol/l higher (0.008-0.028; P < 0.001) apolipoprotein B concentrations. The age at weaning off breast milk was not associated with lipid profile in later life. CONCLUSION: Small body size at birth and slow weight gain during infancy are associated with an atherogenic lipid profile in adult life.
BACKGROUND: Small body size at birth and slow growth during the first 2 years after birth, leading to low body mass index (BMI) at 2 years, are associated with coronary heart disease and stroke in adult life. We tested the hypothesis that this path of growth is associated with an atherogenic lipid profile in later life. METHODS: We measured serum lipid concentrations at age 57-70 years in 1999 members of the Helsinki Birth Cohort. They were randomly selected from an original cohort of 8760 people and had on average 11 measurements of height and weight between birth and 2 years of age. RESULTS: The 18% of subjects who used lipid-lowering medication had a lower BMI at birth and at 2 years. These subjects were excluded from the analyses of lipid profiles. A 1 kg/m(2) lower BMI at birth was associated with 0.051 mmol/l (95% CI -0.001 to 0.103; P = 0.05) higher non-HDL cholesterol and 0.018 g/l higher (0.005-0.031; P = 0.006) apolipoprotein B concentrations. A slower increase in BMI during the first 6 months after birth was associated with lower HDL and higher non-HDL cholesterol concentrations. A 1 kg/m(2) lower BMI at 2 years was associated with 0.020 mmol/l lower (0.004-0.036; P = 0.02) HDL cholesterol and 0.059 mmol/l (0.020-0.099; P = 0.003) higher non-HDL cholesterol and 0.018 mmol/l higher (0.008-0.028; P < 0.001) apolipoprotein B concentrations. The age at weaning off breast milk was not associated with lipid profile in later life. CONCLUSION: Small body size at birth and slow weight gain during infancy are associated with an atherogenic lipid profile in adult life.
Authors: Sribalasubashini Muralimanoharan; Cun Li; Ernesto S Nakayasu; Cameron P Casey; Thomas O Metz; Peter W Nathanielsz; Alina Maloyan Journal: J Mol Cell Cardiol Date: 2017-06-19 Impact factor: 5.000
Authors: Michelle Lampl; Francesca Gotsch; Juan Pedro Kusanovic; Jimmy Espinoza; Luis Gonçalves; Ricardo Gomez; Jyh Kae Nien; Edward A Frongillo; Roberto Romero Journal: Ann Hum Biol Date: 2008 Sep-Oct Impact factor: 1.533
Authors: Lise Geisler Andersen; Lars Angquist; Johan G Eriksson; Tom Forsen; Michael Gamborg; Clive Osmond; Jennifer L Baker; Thorkild I A Sørensen Journal: PLoS One Date: 2010-11-29 Impact factor: 3.240
Authors: Bernardo L Horta; Denise P Gigante; Clive Osmond; Fernando C Barros; Cesar G Victora Journal: Int J Epidemiol Date: 2009-04-17 Impact factor: 7.196
Authors: Yenny Djuardi; Heri Wibowo; Taniawati Supali; Iwan Ariawan; Robbert G M Bredius; Maria Yazdanbakhsh; Laura C Rodrigues; Erliyani Sartono Journal: PLoS One Date: 2009-11-09 Impact factor: 3.240